Aileen M. Gariepy
Yale University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Aileen M. Gariepy.
Fertility and Sterility | 2014
Lisbet S. Lundsberg; Lubna Pal; Aileen M. Gariepy; Xiao Xu; Micheline C. Chu; Jessica L. Illuzzi
OBJECTIVE To assess overall knowledge, attitudes, and practices related to conception and fertility among reproductive-age women in the United States. DESIGN Online survey of a cross-sectional sample of 1,000 women. SETTING United States, March 2013. PATIENT(S) Women aged 18-40 years. INTERVENTION(S) None. MAIN OUTCOME MEASURE(S) Knowledge, attitudes, and practices regarding selected topics in reproductive health. RESULT(S) Forty percent of women across all age groups expressed concerns about their ability to conceive. Yet one-third of women were unaware of adverse implications of sexually transmitted infections, obesity, or irregular menses for procreative success, and one-fifth were unaware of the effects of aging. Approximately 40% were unfamiliar with the ovulatory cycle. Overall, younger women (18-24 years) demonstrated less knowledge regarding conception, fertility, and ovulation, whereas older women tended to believe in common myths and misconceptions. Respondents in all age groups identified womens health care providers (75%) and Web sites (40%) as top sources of reproductive health-related information; however, engagement with providers on specific factors affecting fertility is sparse. CONCLUSION(S) Knowledge regarding ovulation, fertility, and conception is limited among this sample of reproductive-age US women. Future initiatives should prioritize improved provider engagement and accurate information dissemination in Web-based venues.
Contraception | 2011
Aileen M. Gariepy; Erica J. Simon; Divya A. Patel; Mitchell D. Creinin; Eleanor Bimla Schwarz
BACKGROUND The study was conducted to evaluate the impact of out-of-pocket expense on intrauterine device (IUD) utilization among women with private insurance. STUDY DESIGN We reviewed the records of all women with private insurance who requested an IUD for contraception from an urban academic gynecology practice from May 2007 through April 2008. For each patient, we determined the out-of-pocket expense that would be incurred and whether she ultimately had an IUD placed. The total charge for placement of a copper or levonorgestrel IUD (including the device) was
The New England Journal of Medicine | 2015
Sanket S. Dhruva; Joseph S. Ross; Aileen M. Gariepy
815. RESULTS Ninety-five women requested an IUD during the study period. The distribution of out-of-pocket expense was bimodal: less than
Human Reproduction | 2012
Ebelechukwu A. Odiari; Melissa J. Mulla; Anna K. Sfakianaki; Michael J. Paidas; Nancy L. Stanwood; Aileen M. Gariepy; Jan J. Brosens; Lawrence W. Chamley; Vikki M. Abrahams
50 for 35 (37%) women and greater than
Obstetrics & Gynecology | 2011
Aileen M. Gariepy; Mitchell D. Creinin; Eleanor Bimla Schwarz; Kenneth J. Smith
500 for 52 (55%) women. Intrauterine device insertion occurred in 24 (25%) women, 19 of whom had an out-of-pocket expense less than
American Journal of Reproductive Immunology | 2015
Stefan M. Gysler; Melissa J. Mulla; Meredith Stuhlman; Anna K. Sfakianaki; Michael J. Paidas; Nancy L. Stanwood; Aileen M. Gariepy; Jan J. Brosens; Lawrence W. Chamley; Vikki M. Abrahams
50. In univariate and multivariable analysis, women with insurance coverage that resulted in less than
Health Affairs | 2015
Xiao Xu; Aileen M. Gariepy; Lisbet S. Lundsberg; Sangini S. Sheth; Christian M. Pettker; Harlan M. Krumholz; Jessica L. Illuzzi
50 out-of-pocket expense for the IUD were more likely to have an IUD placed than women required to pay
Contraception | 2013
Aileen M. Gariepy; Beatrice A. Chen; Heather L. Hohmann; Sharon L. Achilles; Jennefer A. Russo; Mitchell D. Creinin
50 or more (adjusted odds ratio=11.4, 95% confidence interval=3.6-36.6). CONCLUSIONS Women requesting an IUD for contraception are significantly more likely to have an IUD placed when out-of-pocket expense is less than
Obstetrics & Gynecology | 2015
Aileen M. Gariepy; Jennifer Y. Duffy; Xiao Xu
50.
Fertility and Sterility | 2015
Aileen M. Gariepy; Lisbet S. Lundsberg; Marilyn Stolar; Nancy L. Stanwood; Kimberly A. Yonkers
Essure, a female-sterilization device, is being reevaluated by an FDA panel 13 years after its original approval. Would concerns about its safety and effectiveness have been addressed earlier with better research and result dissemination?